@article{JTD14897,
author = {Salvatore Cassese and Oliver Husser and Adnan Kastrati},
title = {Adverse events with bioresorbable vascular scaffolds in routine percutaneous coronary interventions: “coup de théâtre” or unfinished play?},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {8},
year = {2017},
keywords = {},
abstract = {Bioresorbable scaffolds are percutaneous coronary prostheses designed to ensure transient support of the dilated vessel and dissolution into inert breakdown products overtime (1). By leaving the coronary artery without a permanent metallic implant, bioresorbable scaffolds have been developed to absolve three main commitments: improve long-term vessel healing and remodelling, restore vasomotor function of the treated segment, and reduce the burden of angina symptoms in comparison with conventional drug-eluting stent (DES) platforms.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/14897}
}